When individuals encounter coMra therapy for the first time, a frequent concern is whether the treatment might inadvertently amplify an infection, such as a fungus, virus, or bacteria, especially when treating wounds or non-healing ulcers. Arzhan Surazakov clarifies that coMra therapy does not work like medication, which often aims to manipulate or control specific biological processes. Instead, a coMra device creates the optimal conditions for the organism to rebuild and restore itself. It does not grow or destroy pathogens; rather, it supports the immune system in performing its natural function.
Arzhan Surazakov explains that the effect of coMra therapy is always context-dependent. If a patient has a weak immune system struggling to overcome an infection, the therapy provides the resources needed to enhance the inflammatory response, which may show as elevated markers in a blood test. Conversely, in cases of autoimmune disease or chronic inflammation where the immune system is overactive and attacking healthy tissue, coMra therapy helps normalize that response, leading to a reduction in inflammatory markers back to a healthy range.
Because the healing process involves different phases—requiring an active immune response during the acute phase of injury and a shift toward tissue regeneration during recovery—the body must constantly adjust its internal state. It is not the role of the coMra device to decide which phase is necessary; the body’s own intelligence determines the required response. As noted in the discussion, while short-term tests might show fluctuations in immune markers, the long-term trajectory of healing consistently moves in the right direction when the body is provided with the necessary support.